3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Castration Levels of Testosterone: new trials by email Literature Review of Castration Levels of Testosterone trials Research Report on Castration Levels of Testosterone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981, Nivolumab - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma | Phase 2 | Terminated | Barbara Ann Karmanos Cancer Institute | 10 | 2019-11-13 | 2024-07-16 |
| Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency Carboplatin, Docetaxel, Laboratory Biomarker Analysis - ATM Gene Mutation, BRCA1 Gene Mutation | Phase 2 | Terminated | University of Washington | 18 | 2018-08-24 | 2026-08-26 |
| Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer Selinexor - Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer | Phase 2 | Terminated | University of California, San Francisco | 14 | 2014-09-02 | 2018-06-26 |
Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one (1) · Carboplatin (1) · Docetaxel (1) · Nivolumab (1) · rucaparib (1) · selinexor (1)
Barbara Ann Karmanos Cancer Institute (1) · University of California, San Francisco (1) · University of Washington (1)
United States (3)
Charles Ryan, MD (1) · Elisabeth Heath, M.D. (1) · Heather H. Cheng (1)
P30CA022453 (1)